These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9359845)

  • 1. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA.
    van Berkel PH; Geerts ME; van Veen HA; Mericskay M; de Boer HA; Nuijens JH
    Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):145-51. PubMed ID: 9359845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.
    Legrand D; van Berkel PH; Salmon V; van Veen HA; Slomianny MC; Nuijens JH; Spik G
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):841-6. PubMed ID: 9581564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of monoclonal antibodies against human lactoferrin.
    van Berkel PH; van Veen HA; Geerts ME; Nuijens JH
    J Immunol Methods; 2002 Sep; 267(2):139-50. PubMed ID: 12165435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis.
    van Berkel PH; Geerts ME; van Veen HA; Kooiman PM; Pieper FR; de Boer HA; Nuijens JH
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):107-14. PubMed ID: 7492299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.
    Elass-Rochard E; Roseanu A; Legrand D; Trif M; Salmon V; Motas C; Montreuil J; Spik G
    Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):839-45. PubMed ID: 8554529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of recombinant human lactoferrin secreted in milk of transgenic mice.
    Nuijens JH; van Berkel PH; Geerts ME; Hartevelt PP; de Boer HA; van Veen HA; Pieper FR
    J Biol Chem; 1997 Mar; 272(13):8802-7. PubMed ID: 9079716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical cation-exchange chromatography to assess the identity, purity, and N-terminal integrity of human lactoferrin.
    van Veen HA; Geerts ME; van Berkel PH; Nuijens JH
    Anal Biochem; 2002 Oct; 309(1):60-6. PubMed ID: 12381362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level expression of bioactive recombinant human lysozyme in the milk of transgenic mice using a modified human lactoferrin BAC.
    Liu S; Li X; Lu D; Shang S; Wang M; Zheng M; Zhang R; Tang B; Li Q; Dai Y; Li N
    Transgenic Res; 2012 Apr; 21(2):407-14. PubMed ID: 21805108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein.
    Elass-Rochard E; Legrand D; Salmon V; Roseanu A; Trif M; Tobias PS; Mazurier J; Spik G
    Infect Immun; 1998 Feb; 66(2):486-91. PubMed ID: 9453600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14.
    Caccavo D; Afeltra A; Pece S; Giuliani G; Freudenberg M; Galanos C; Jirillo E
    Infect Immun; 1999 Sep; 67(9):4668-72. PubMed ID: 10456914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the first N-terminal basic cluster of human lactoferrin (R2R3R4R5) in the interactions with the Jurkat human lymphoblastic T-cells.
    Legrand D; van Berkel PH; Salmon V; van Veen HA; Slomianny MC; Nuijens JH; Spik G
    Adv Exp Med Biol; 1998; 443():49-55. PubMed ID: 9781342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of bi-transgenic pigs overexpressing human lactoferrin and lysozyme in milk.
    Cui D; Li J; Zhang L; Liu S; Wen X; Li Q; Zhao Y; Hu X; Zhang R; Li N
    Transgenic Res; 2015 Apr; 24(2):365-73. PubMed ID: 25236863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-binding properties of lactoferrin and lysozyme.
    Zou S; Magura CE; Hurley WL
    Comp Biochem Physiol B; 1992 Dec; 103(4):889-95. PubMed ID: 1478067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of binding of lactoferrin to the human promonocyte cell line THP-1 by heparin: the role of cell surface sulphated molecules.
    Roşeanu A; Chelu F; Trif M; Motaş C; Brock JH
    Biochim Biophys Acta; 2000 Jun; 1475(1):35-8. PubMed ID: 10806335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis.
    van Veen HA; Geerts ME; van Berkel PH; Nuijens JH
    Eur J Biochem; 2004 Feb; 271(4):678-84. PubMed ID: 14764083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-reducing terminal fucose within N-linked glycan plays a significant role in the recognition of human milk lactoferrin by the 1CF11 monoclonal antibody.
    Fukaya S; Yabe T; Kanamaru Y
    Biosci Biotechnol Biochem; 2010; 74(10):2141-4. PubMed ID: 20944405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants.
    van Berkel PH; van Veen HA; Geerts ME; de Boer HA; Nuijens JH
    Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):117-22. PubMed ID: 8870657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of basic residues of human lactoferrin in the interaction with B lymphocytes.
    Kawasaki Y; Sato K; Shinmoto H; Dosako S
    Biosci Biotechnol Biochem; 2000 Feb; 64(2):314-8. PubMed ID: 10737187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of human lactoferrin in animal milk.
    Goldman IL; Georgieva SG; Gurskiy YG; Krasnov AN; Deykin AV; Popov AN; Ermolkevich TG; Budzevich AI; Chernousov AD; Sadchikova ER
    Biochem Cell Biol; 2012 Jun; 90(3):513-9. PubMed ID: 22360490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing the chondroitin sulfate-binding characteristics of human lactoferrin to neutralize neurite outgrowth inhibition.
    Nakamura M; Matsuzaki T; Iimori A; Sato A
    Biochem Biophys Res Commun; 2021 Jan; 534():1076-1082. PubMed ID: 33129446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.